Effects of cannabinoids on endogenous K+ and Ca2+ currents in HEK293 cells
- 1 May 2003
- journal article
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 81 (5), 436-442
- https://doi.org/10.1139/y03-055
Abstract
Effects of cannabinoids on endogenous potassium and calcium currents in HEK293 cells were studied using the whole-cell variant of the patch-clamp technique. The cannabinoid agonists WIN 55,212-2, methanandamide, and anandamide (1 μM) decreased the calcium current by 53.1 ± 2.6, 47.5 ± 1.2, and 38.8 ± 3.1%, respectively, after transfection of human CB1 cannabinoid receptor (hCB1) cDNA into HEK293 cells. The delayed rectifier-like current was not changed after application of these agonists, but the inward rectifier was increased by 94.0 ± 3.6, 83.7 ± 5.1, and 63.0 ± 2.5% after application of WIN 55,212-2, methanandamide, and anandamide, respectively. The effects of the cannabinoid antagonists (AM251, AM281, and AM630) on the inward rectifier and calcium currents were the opposite of those seen with cannabinoid agonists; thus, these compounds act as inverse agonists in this preparation. These results suggest that endogenous inward rectifier and calcium currents are modulated by cannabinoids in HEK293 cells, and that some expressed receptors may be constitutively active.Key words: cannabinoids, WIN 55,212-2, anandamide, methanandamide, inverse agonists.Keywords
This publication has 23 references indexed in Scilit:
- Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamideThe EMBO Journal, 2001
- Influence of cannabinoids on the delayed rectifier in freshly dissociated smooth muscle cells of the rat aortaBritish Journal of Pharmacology, 2000
- Selective Regulation of Endogenous G Protein-coupled Receptors by Arrestins in HEK293 CellsPublished by Elsevier ,2000
- Agonist‐inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656 and AM630British Journal of Pharmacology, 1999
- Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptorsBritish Journal of Pharmacology, 1998
- SR141716A is an inverse agonist at the human cannabinoid CB1 receptorEuropean Journal of Pharmacology, 1997
- Endogenous calcium channels in human embryonic kidney (HEK293) cellsBritish Journal of Pharmacology, 1996
- AM630, a competitive cannabinoid receptor antagonistLife Sciences, 1995
- Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 1990
- Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patchesPflügers Archiv - European Journal of Physiology, 1981